Active ingredientIohexolCat. No. P-I058-001CAS 66108-95-0Family · Pharmaceutical analytical standards
Iohexol
A low-osmolality non-ionic iodinated contrast agent, developed in Norway and introduced in the mid-1980s: it makes blood vessels, organs and the spinal canal visible in X-ray, CT and angiography. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?The idea of non-ionic contrast agents came to Swedish radiologist Torsten Almén: salty seawater stung his eyes while the brackish water near Ystad did not, and he guessed that the pain depended on osmolality.
Go to the active ingredient →Active ingredientIohexolCat. No. P-I058-001CAS 66108-95-0
Pharmacopoeial impurityIohexol EP Impurity ACat. No. P-I058-002CAS 31127-80-7
Pharmacopoeial impurityIohexol EP Impurity B (Mixture of Diastereomers)Cat. No. P-I058-003CAS 2732209-64-0
Pharmacopoeial impurityIohexol EP Impurity C (Mixture of Diastereomers)Cat. No. P-I058-004CAS 2724765-15-3
Pharmacopoeial impurityIohexol EP Impurity D (Mixture of Diastereomers)Cat. No. P-I058-005CAS 157739-09-8
Pharmacopoeial impurityIohexol EP Impurity E (Mixture of Diastereomers)Cat. No. P-I058-006CAS 2727061-52-9
Pharmacopoeial impurityIohexol EP Impurity F (2,4-diiodo Isomer)Cat. No. P-I058-007CAS 1215856-35-1
Pharmacopoeial impurityIohexol EP Impurity F HCl (4,6-diiodo Isomer)Cat. No. P-I058-008
Pharmacopoeial impurityIohexol EP Impurity F HCl (2,4-diiodo Isomer)Cat. No. P-I058-009
Pharmacopoeial impurityIohexol EP Impurity G (2,4-diiodo Isomer)Cat. No. P-I058-010
Pharmacopoeial impurityIohexol EP Impurity G (4,6-diiodo Isomer)Cat. No. P-I058-011
Pharmacopoeial impurityIohexol EP Impurity H (2,4-diiodo Isomer)Cat. No. P-I058-012CAS 1651211-78-7
Pharmacopoeial impurityIohexol EP Impurity H (4,6-diiodo Isomer) (Mixture of Diastereomers)Cat. No. P-I058-013CAS 1651211-79-8
Pharmacopoeial impurityIohexol EP Impurity ICat. No. P-I058-014CAS 196309-19-0
Pharmacopoeial impurityIohexol EP Impurity JCat. No. P-I058-015CAS 76801-93-9
Pharmacopoeial impurityIohexol EP Impurity KCat. No. P-I058-016CAS 35453-19-1
Pharmacopoeial impurityIohexol EP Impurity LCat. No. P-I058-017CAS 37441-29-5
Isotopically labelled(R)-Iohexol-d5Cat. No. P-I058-019
Isotopically labelled(S)-Iohexol-d5Cat. No. P-I058-020
Isotopically labelledIohexol-d5Cat. No. P-I058-021CAS 928623-33-0
Impurity(R)-IohexolCat. No. P-I058-022
Impurity(S)-IohexolCat. No. P-I058-023
ImpurityIohexol Impurity 1Cat. No. P-I058-024CAS 219851-75-9
ImpurityIohexol Impurity 2Cat. No. P-I058-025CAS 76820-35-4
Pharmacopoeial impurityIohexol EP Impurity F (4,6-diiodo Isomer)Cat. No. P-I058-026
ImpurityIohexol Impurity 3Cat. No. P-I058-028CAS 267881-77-6
ImpurityIohexol Impurity 4Cat. No. P-I058-029CAS 1260020-77-6
ImpurityIohexol Impurity 5Cat. No. P-I058-030
ImpurityIohexol Impurity 6Cat. No. P-I058-031CAS 1096689-22-3
ImpurityIohexol Impurity 7Cat. No. P-I058-032
ImpurityIohexol Impurity 8Cat. No. P-I058-033CAS 76350-23-7
ImpurityIohexol Impurity 9Cat. No. P-I058-034
ImpurityIohexol Impurity 10Cat. No. P-I058-035CAS 92339-10-1
ImpurityIohexol Impurity 11Cat. No. P-I058-036
ImpurityIohexol Impurity 12Cat. No. P-I058-037
ImpurityIohexol Impurity 13Cat. No. P-I058-038
ImpurityIohexol Impurity 15Cat. No. P-I058-040
ImpurityIohexol Impurity 16Cat. No. P-I058-041
ImpurityIohexol Impurity 17Cat. No. P-I058-042
ImpurityIohexol Impurity 18Cat. No. P-I058-043
ImpurityIohexol Impurity 19Cat. No. P-I058-044
ImpurityIohexol Impurity 20Cat. No. P-I058-045
ImpurityIohexol Impurity 21Cat. No. P-I058-046
Pharmacopoeial impurityIohexol USP Related Compound CCat. No. P-I058-047CAS 76820-34-3No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
Reference substanceIohexol CRSEDQM code I0320800Family IohexolImpurityIohexol impurity A CRSEDQM code I0320810Family IohexolImpurityIohexol impurity J CRSEDQM code I0320820Family IohexolNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.